Ethnic minority groups less informed about cancer symptoms
the ONA take:
According to new findings presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, United Kingdom, ethnic minorities in England were less informed about cancer symptoms and were less likely to see a doctor when they thought they had a possibly serious symptom.
Researchers at King's College London in London, United Kingdom, analyzed about 50,000 responses from the Cancer Research UK Cancer Awareness Measure, a national population-based survey to investigate levels of cancer awareness. Researchers found that people with a black ethnic background were half as likely as white people to identify unexplained bleeding as a possible cancer symptom.
People of South Asian descent were a one-fourth as likely as white people to identify an explained lump as a possible cancer symptom. In addition, people with South Asian backgrounds were more likely to report embarrassment and low confidence to discuss their symptoms with their doctor, while white people were more concerned about wasting the physician's time.
The findings suggest that more public awareness is needed to help people identify cancer symptoms earlier in disease progression and that people need to be encouraged to discuss unexplained changes in their body with their physician.
Ethnic minorities less informed about cancer symptoms and less likely to see a doctor.
Ethnic minorities in England are less aware of cancer symptoms and more likely to say they wouldn't see the doctor, even when they have a symptom that they think might be serious, according to research being presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Researchers looked at nearly 50,000 responses to the Cancer Research UK Cancer Awareness Measure* from people across England. They found that ethnic minority groups were consistently less aware of cancer symptoms.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- CQGS Releases Standards for Surgical Care of Older Adults
- Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy
- Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|